Hosted on MSN3mon
Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases
The PFS delivers the same drug as the currently available 6.0 mg Vabysmo vials in an alternative, ready-to-use format. Per Roche, Vabysmo PFS will be the EU’s first and only prefilled syringe ...
Medscape10d
Vaccine Presentation in the USA: Economics of Prefilled Syringes versus Multidose Vials for Influenza Vaccination
The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...
Asian News International on MSN6d
Sovereign Pharma Achieves Prestigious EU Approval for Aseptic and Terminally Sterilized Injectable Products
Sovereign Pharma, a leader in high-quality injectable manufacturing, proudly announces its milestone: EU approval for aseptic ...
The Financial Express28d
Biocon Biologics launches biosimilar to treat Crohn’s disease in United States
The available presentations are 45 mg/0.5 mL PFS, 90 mg/mL PFS, 45 mg/0.5 mL vial, and 130 mg/26 mL vial. (Image Credits: Pixabay) According to the company’s statement, YESINTEK is approved for ...
Yahoo Finance29d
Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States
The available presentations are 45 mg/0.5 mL PFS, 90 mg/mL PFS, 45 mg/0.5 mL vial, and 130 mg/26 mL vial. Shreehas Tambe, CEO & Managing Director, Biocon Biologics Ltd, said: "The launch of ...
Pharmabiz6d
Sovereign Pharma achieves EU approval for aseptic and terminally sterilized injectable products
Sovereign Pharma achieves EU approval for aseptic and terminally sterilized injectable products: Our Bureau, Bengaluru Wednesday, March 19, 2025, 14:45 Hrs [IST] Sovereign Pharma, ...